413 related articles for article (PubMed ID: 28388717)
1. Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.
Nestor M; Ablon G; Pickett A
Aesthet Surg J; 2017 May; 37(suppl_1):S20-S31. PubMed ID: 28388717
[TBL] [Abstract][Full Text] [Related]
2. The Practical Use of AbobotulinumtoxinA in Aesthetics.
Kane MA; Monheit G
Aesthet Surg J; 2017 May; 37(suppl_1):S12-S19. PubMed ID: 28388719
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin: examining duration of effect in facial aesthetic applications.
Flynn TC
Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
[TBL] [Abstract][Full Text] [Related]
4. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.
Wilson AJ; Chang B; Taglienti AJ; Chin BC; Chang CS; Folsom N; Percec I
Plast Reconstr Surg; 2016 May; 137(5):1424-1433. PubMed ID: 27119918
[TBL] [Abstract][Full Text] [Related]
5. New Uses of AbobotulinumtoxinA in Aesthetics.
Schlessinger J; Gilbert E; Cohen JL; Kaufman J
Aesthet Surg J; 2017 May; 37(suppl_1):S45-S58. PubMed ID: 28388720
[TBL] [Abstract][Full Text] [Related]
6. AbobotulinumtoxinA: A 25-Year History.
Monheit GD; Pickett A
Aesthet Surg J; 2017 May; 37(suppl_1):S4-S11. PubMed ID: 28388718
[TBL] [Abstract][Full Text] [Related]
7. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
Wortzman MS; Pickett A
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
[TBL] [Abstract][Full Text] [Related]
8. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.
Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1278-84. PubMed ID: 20337830
[TBL] [Abstract][Full Text] [Related]
9. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC
J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles.
Michaels BM; Csank GA; Ryb GE; Eko FN; Rubin A
Aesthet Surg J; 2012 Jan; 32(1):96-102. PubMed ID: 22231417
[TBL] [Abstract][Full Text] [Related]
11. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.
Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1285-95. PubMed ID: 20569284
[TBL] [Abstract][Full Text] [Related]
12. Clinical Assessment of 2 Licensed AbobotulinumtoxinA Injection Volumes for the Treatment of Glabellar Lines.
Kaufman J; Cohen JL; Peredo MI; Jonas B; Down R; Nogueira A
Dermatol Surg; 2019 Oct; 45(10):1274-1284. PubMed ID: 30893159
[TBL] [Abstract][Full Text] [Related]
13. Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.
Cohen JL; Scuderi N
Aesthet Surg J; 2017 May; 37(suppl_1):S32-S44. PubMed ID: 28388721
[TBL] [Abstract][Full Text] [Related]
14. Overview of Botulinum Toxins for Aesthetic Uses.
Gart MS; Gutowski KA
Clin Plast Surg; 2016 Jul; 43(3):459-71. PubMed ID: 27363760
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
Matarasso A; Shafer D
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
[TBL] [Abstract][Full Text] [Related]
17. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
Chang BL; Wilson AJ; Taglienti AJ; Chang CS; Folsom N; Percec I
Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
[TBL] [Abstract][Full Text] [Related]
18. Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial.
Hexsel D; Hexsel C; Siega C; Schilling-Souza J; Rotta FT; Rodrigues TC
JAMA Dermatol; 2013 Dec; 149(12):1386-91. PubMed ID: 24108521
[TBL] [Abstract][Full Text] [Related]
19. The use of botulinum toxin type A in cosmetic facial procedures.
Jaspers GW; Pijpe J; Jansma J
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.
Rzany B; Fratila AA; Fischer TC; Hilton S; Pavicic T; Rothhaar A; Sattler G; Sommer B; Pickett A
J Drugs Dermatol; 2013 Jan; 12(1):80-4. PubMed ID: 23377332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
